Allarity Therapeutics ALLR
NASDAQ ALLR
$1.04 +0.00 (+0.00%)
At close: Oct 2, 2026 · 4:00 PM EDT

Allarity Therapeutics (ALLR) Price to Sales (2026)

Updated

Allarity Therapeutics' Price to Sales came in at 82.92 for Q2 2026.

Analysis

Allarity Therapeutics (ALLR) Price to Sales (2026) Analysis & Trends

For FY2025, Allarity Therapeutics' Price to Sales was 5.42.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn
10 Allarity Therapeutics 1.67 Mn 1.67 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 82.92
API Access

Allarity Therapeutics Price to Sales API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=price-to-sales&ticker=ALLR&period=max&api_key=YOUR_API_KEY